Disease-Free Survival Advantage of Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Patients With Node-Negative, Rapidly Proliferating Breast Cancer: A Randomized Multicenter Study
Dino Amadori(Ospedale G.B. Morgagni - L.Pierantoni), Annalisa Volpi(Florence (Netherlands)), A. Tienghi(Florence (Netherlands)), Andrea Rossi(Fondazione Toscana Gabriele Monasterio), Donata Casadei Giunchi(Florence (Netherlands)), D. Perroni(Florence (Netherlands)), Oriana Nanni(National Institutes of Health), Giuseppina Catalano(Unknown), Aldo Becciolini(Florence (Netherlands)), M. Marangolo(Florence (Netherlands)), Alberto Ravaioli(Florence (Netherlands)), Emanuela Scarpi(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Angelo Gambi(Florence (Netherlands)), P Pacini
Cited by 58
Related Papers
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
|European Respiratory Journal|2004|4.4k
Neuroprotective Effect of Reduced Glutathione on Oxaliplatin-Based Chemotherapy in Advanced Colorectal Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial
|Journal of Clinical Oncology|2002|416
Etiologic Heterogeneity Among Non-Hodgkin Lymphoma Subtypes: The InterLymph Non-Hodgkin Lymphoma Subtypes Project
|JNCI Monographs|2014|334
Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized, double-blind trial with placebo.
|Journal of Clinical Oncology|1994|200
Independent Relationship of Left Atrial Size and Mortality in Patients with Heart Failure: An Individual Patient Meta-Analysis of Longitudinal Data (MeRGE Heart Failure)
|European Journal of Heart Failure|2009|168